Empire Genomics (www.empiregenomics.com) entered into a strategic alliance with BioDiscovery (www.biodiscovery.com) to provide complete solutions to customers carrying out research involving array comparative genomic hybridization. Empire’s aCGH services and products will be combined with BioDiscovery’s software to reduce the difficulty in obtaining high quality data from assays.
The companies will co-market and co-promote their products and services to end users. Empire Genomics and BioDiscovery say that their products will ensure consistency from assay to assay and researcher to researcher. The firms will also work to develop and bring new products to market.
